ASCO: In stomach cancer, AstraZeneca and Daiichi’s Enhertu goes where Roche’s Kadcyla couldn’t

In a pivotal study, patients taking Enhertu from AstraZeneca and Daiichi Sankyo saw their tumors shrink and were still alive after a year, researcher said at the recent ASCO meeting.